EUVIMEDEUVIMED entdecken
Crossref

2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 Deficiency

Charlyne Brakta, Anne-Claude Tabet, Mathilde Puel, Mathilde Pacault, Marie-Claude Stolzenberg, Claire Goudet, Marguerite Merger, Héloïse Reumaux, Nathalie Lambert, Najiba Alioua, Valérie Malan, Sylvain Hanein und 25 weitere

Journal of Clinical Immunology · 2025-12 · 45 (1)

DOI: 10.1007/s10875-024-01831-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 23.11.2024. Verfasst von Charlyne Brakta und 36 weiteren Autor:innen. Beteiligte Einrichtung: Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Chromosomes, Human, Pair 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: CTLA4 deficiency is an inborn error of immunity (IEI) due to heterozygosity for germline loss-of-function variants of the CTLA4 gene located on chromosome 2q33.2. CTLA4 deficiency underlies pleiotropic immune and lymphoproliferation-mediated features with incomplete penetrance. It has been identified in hundreds of patients but copy number variants (CNVs) have been reported in only 12 kindreds, including nine which displayed large 2q33.1-2q33.2 deletions encompassing CTLA4. METHODS: We conducted a nationwide study in France to identify patients with 2q33 deletions encompassing CTLA4. We investigated the clinical and immunological phenotypes and genotypes of these patients. RESULTS: We identified 12 patients across six unrelated kindreds with clinical immunodeficiency. Neurological features were recorded in three patients, including one with syndromic neurodevelopmental disorder. Single-nucleotide polymorphism (SNP) or comparative genomic hybridization (CGH) array analysis, and targeted high-throughput sequencing revealed five different heterozygous 2q33 deletions of 26 kilobases to 7.12 megabases in size and encompassing one to 41 genes. We identified a contiguous gene syndrome (CGS) due to associated KLF7 deficiency in a kindred with a neurodevelopmental phenotype. CONCLUSION: Deletions within the 2q33 region encompassing CTLA4 are rare and not extensively explored, and are probably underdiagnosed in cytogenetic practice. A literature review identified 14 different CGS loci including at least one gene responsible for an IEI. The deletions involved in IEIs should be systematically delimited, to facilitate screening for CGS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CTLA-4 AntigenChromosomes, Human, Pair 2HumansMaleFemaleChildChild, PreschoolPhenotypeChromosome DeletionInfantFrancePedigreePolymorphism, Single NucleotideComparative Genomic HybridizationSyndromeDNA Copy Number VariationsAdolescentGenetic Predisposition to DiseaseGenotype

Stichwörter der Autor:innen

2q33 deletionCTLA4 (cytotoxic T lymphocyte-associated protein 4) deficiencyContiguous gene syndromeCopy number variationsCytogeneticsKLF7

Substanzen

CTLA-4 AntigenCTLA4 protein, human

Autor:innen und Institutionen

  • Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, EU, France.
  • Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, EU, France.
  • Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, UMR 1163, Imagine Institute, INSERM, Paris, EU, France.
  • Inserm U1163, Imagine Institute, University of Paris Cité, Paris, Paris, EU, France.
  • Pediatric Hematology Department, Timone Enfant, Assistance Publique Hôpitaux de Marseille (AP-HM), Marseille, EU, France.
  • Department of Internal Medicine and Clinical Immunology, University of Lille, Lille, EU, France.

Förderung

  • Agence Nationale de la Recherche

Zitieren

APA

Brakta, C., Tabet, A. C., Puel, M., Pacault, M., Stolzenberg, M. C., Goudet, C., Merger, M., Reumaux, H., Lambert, N., Alioua, N., Malan, V., Hanein, S., Dupin-Deguine, D., Treiner, E., Lefèvre, G., Farhat, M. M., Luca, L. E., Hureaux, M., Li, H., …, & Rosain, J. (2025). 2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 Deficiency. Journal of Clinical Immunology, 45(1). https://doi.org/10.1007/s10875-024-01831-5

Vancouver

Brakta C, Tabet AC, Puel M, Pacault M, Stolzenberg MC, Goudet C, et al. 2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 Deficiency. Journal of Clinical Immunology. 2025;45(1). doi:10.1007/s10875-024-01831-5

BibTeX
@article{Brakta2025,
  author = {Brakta, Charlyne and Tabet, Anne-Claude and Puel, Mathilde and Pacault, Mathilde and Stolzenberg, Marie-Claude and Goudet, Claire and Merger, Marguerite and Reumaux, Héloïse and Lambert, Nathalie and Alioua, Najiba and Malan, Valérie and Hanein, Sylvain and Dupin-Deguine, Delphine and Treiner, Emmanuel and Lefèvre, Guillaume and Farhat, Méryem-Maud and Luca, Luminita Elena and Hureaux, Marguerite and Li, Hailun and Chelloug, Nora and Dehak, Rabha and Boussion, Simon and Ouachée-Chardin, Marie and Schleinitz, Nicolas and Abou Chahla, Wadih and Barlogis, Vincent and Vély, Frédéric and Oksenhendler, Eric and Quartier, Pierre and Pasquet, Marlène and Suarez, Felipe and Bustamante, Jacinta and Neven, Bénédicte and Picard, Capucine and Rieux-Laucat, Frédéric and Lévy, Jonathan and Rosain, Jérémie},
  title = {2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 Deficiency},
  journal = {Journal of Clinical Immunology},
  year = {2025},
  volume = {45},
  number = {1},
  doi = {10.1007/s10875-024-01831-5}
}
Kostenlos starten →